HCL Tech shares have plunged sharply after weak Q4 earnings and subdued FY27 guidance, triggering multiple broker downgrades and target cuts. Concerns over slowing growth, reduced discretionary spending, and limited visibility on recovery have weighed on sentiment, with analysts expecting continued pressure on the stock in the near term.